NCT03792841 2025-10-16
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
Amgen
Phase 1 Terminated
Amgen
National Institutes of Health Clinical Center (CC)
Innovaderm Research Inc.
Haukeland University Hospital
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio